Suzanne Thompson, RN | |
983 Maypole Dr, Apopka, FL 32703-8307 | |
(321) 201-5320 | |
Not Available |
Full Name | Suzanne Thompson |
---|---|
Gender | Female |
Speciality | Clinic/center - Developmental Disabilities |
Location | 983 Maypole Dr, Apopka, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841901766 | NPI | - | NPPES |
108455700 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WH0200X | Registered Nurse - Home Health | RN9388077 (Florida) | Secondary |
261QD1600X | Clinic/center - Developmental Disabilities | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Suzanne Thompson, RN 983 Maypole Dr, Apopka, FL 32703-8307 Ph: (321) 201-5320 | Suzanne Thompson, RN 983 Maypole Dr, Apopka, FL 32703-8307 Ph: (321) 201-5320 |
News Archive
To kick off the holiday season, Emeritus Senior Living has launched a video series that provides valuable tips and information to help seniors – and those who love and care for them – lead safer and healthier lives.
To prepare the multidisciplinary cancer care team for the growing prevalence of cancer and comorbidities among our nation's graying population, the Association of Community Cancer Centers—in collaboration with The Gerontological Society of America and the International Society of Geriatric Oncology—has developed new tools and resources, offering expert insights through its Multidisciplinary Approaches to Caring for Geriatric Patients with Cancer program.
Attorney General Martha Coakley yesterday recommended approval of the proposed sale of Caritas Christi Health Care to a New York private equity firm, a deal that would bring for-profit health care on a large scale to a state long dominated by nonprofit hospitals.
DelMar Pharmaceuticals, Inc. announced the presentation of interim clinical data from the company's ongoing clinical trial with VAL-083 in refractory glioblastoma multiforme (GBM) during the Central Nervous System Tumor Session at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held at the McCormick Place Convention Center in Chicago.
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
› Verified 8 days ago